K093663

Substantially Equivalent

RADIONUCLIDE BRACHYTHERAPY SOURCE

Applicant: C.R. Bard, Inc.
Product code: KXK
Advisory panel: Radiology
Date received: 2009-11-25
Decision date: 2009-12-23
Decision: Substantially Equivalent
Clearance type: Special
Location: Covington, GA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.